p53 DNA binding can be modulated by factors that alter the conformational equilibrium

EMBO Journal

Volumn 18, Issue 3, 1999, Pages 763-770

  McLure, Kevin G ^a,b   Lee, Patrick W K ^a  

^a Health Sciences Centre Calgary   (Canada)

^b ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

Conformational states; DNA binding; p53; p53 DNA complex; pAb240

Indexed keywords

DIMER; DNA; MUTANT PROTEIN; PROTEIN P53; REGULATOR PROTEIN; TETRAMER;

ARTICLE; COMPLEX FORMATION; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN DNA BINDING;

ANIMALS; BASE SEQUENCE; BINDING SITES; CONSENSUS SEQUENCE; DIMERIZATION; DNA; DRUG STABILITY; GENOTYPE; HUMANS; MICE; MUTATION; PROTEIN CONFORMATION; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0033081465     PISSN: 02614189     EISSN: None     Source Type: Journal    
DOI: 10.1093/emboj/18.3.763     Document Type: Article

References (33)

1. Blagosklonny, M.V., Toretsky, J., Bohen, S. and Neckers, L. (1996) Mutant conformation of p53 translated in vitro or in vivo requires functional HSP90. Proc. Natl Acad. Sci. USA, 93, 8379-8383.
2. Chen, Y., Chen, P.-L. and Lee, W.H. (1994) Hot-spot p53 mutants interact specifically with two cellular proteins during progression of the cell cycle. Mol. Cell. Biol., 14, 6764-6772.
3. Cho, Y., Gorina, S., Jeffrey, P.D. and Pavletich, N.P. (1994) Crystal structure of a p53 tumor suppressor -DNA complex: understanding tumorigenic mutations. Science, 265, 346-355.
4. Cook, A. and Milner, J. (1990) Evidence for allosteric variants of wild-type p53, a tumour suppressor protein. Br. J. Cancer, 61, 548-552.
5. Friend, S. (1994) p53: a glimpse at the puppet behind the shadow play. Science, 265, 334-335.
6. Gannon, J.V., Greaves, R., Iggo, R. and Lane, D.P. (1990) Activating mutations in p53 produce a common conformational effect - a monoclonal antibody specific for the mutant form. EMBO J., 9, 1595-1602.
7. Gorina, S. and Pavletich, N.P. (1996) Structure of the p53 tumor suppressor hound to the ankyrin and SH3 domains of 53BP2. Science, 274, 1001-1005.
8. Hainaut, P. and Milner, J. (1992) Interaction of heat-shock protein 70 with p53 translated in vitro: evidence for interaction with dimeric p53 and for a role in the regulation of p53 conformation. EMBO J., 11, 3513-20.
9. Hainaut P. and Milner J. (1993) Redox modulation of p53 conformation and sequence-specific DNA binding in vitro. Cancer Res., 53, 4469-4473.
10. Hainaut, P., Rolley, N., Davies, M. and Milner, J. (1995) Modulation by copper of p53 conformation and sequence-specific DNA binding: role for Cu (II)/Cu (I) redox mechanism. Oncogene, 10, 27-32.
11. Halazonetis, T.D. and Kandil, A.N. (1993) Conformational shifts propagate from the oligomerization domain of p53 to its tetrameric DNA binding domain and restore DNA binding to select p53 mutants. EMBO J., 12, 5057-5064.
12. Halazonetis, T.D., Davis, L.J. and Kandil, A.N. (1993) Wild-type p53 adopts a 'mutant'-like conformation when bound to DNA. EMBO J., 12, 1021-1028.
13. Hall, A.R. and Milner, J. (1995) Structural and kinetic analysis of p53-DNA complexes and comparison of human and murine p53. Oncogene,. 10, 561-567.
14. Hollstein, M., Shomer, B., Greenblatt, M., Soussi, T., Hovig, E., Montesano, R. and Harris, C.C. (1996) Somatic point mutations in the p53 gene of human tumors and cell lines: updated compilation. Nucleic Acids Res., 24, 141-146.
15. Hupp, T.R., Meek, D.W., Midgley, C.A. and Lane, D.P. (1992) Regulation of the specific DNA binding function of p53. Cell, 71, 875-886.
16. Hupp, T.R., Sparks, A. and Lane, D.P. (1995) Small peptides activated the latent sequence-specific DNA binding function of p53. Cell, 83, 237-245.
17. Iwabuchi, K., Bartel, P.L., Li, B., Marraccino, R. and Fields, S. (1994) Two cellular proteins that bind to wild type but not mutant p53. Proc. Natl Acad. Sci. USA, 91, 6098-6102.
18. Jayaraman, L., Murthy, K.G., Zhu, C., Curran, T., Xanthoudakis, S. and Prives, C. (1997) Identification of redox/repair protein Ref-1 as a potent activator of p53. Genes Dev., 11, 558-570.
19. Koshland, D.L., Jr, Nemethy, G. and Filmer, D. (1966) Comparison of experimental binding data and theoretical models in proteins containing subunits. Biochemistry, 5, 365-385.
20. Legros, Y., Meyer, A., Ory, K. and Soussi, T. (1994) Mutations in p53 produce a common conformational effect that can be detected with a panel of monoclonal antibodies directed toward the central part of the p53 protein. Oncogene, 9, 3689-3694.
21. + conformation of wild type p53 binds DNA. Oncogene, 13, 1297-1303.
22. McLure, K.G. and Lee, P.W.K. (1998) How p53 binds DNA as a tetramer. EMBO J., 17, 3342-3350.
23. Milner, J. (1995) Flexibility: the key to p53 function? Trends Biochem. Sci., 20, 49-51.
24. Milner, J. and Cook, A. (1986) The cellular tumour antigen p53: evidence for transformation-related, immunological variants of p53. Virology, 154, 21-30.
25. Milner, J. and Medcalfe, E.A. (1990) Temperature-dependent switching between 'wild-type' and 'mutant' forms of p53-Va1135. J. Mol. Biol., 216, 481-484.
26. Milner J. and Watson J.V. (1990) Addition of fresh medium induces cell cycle and conformation changes in p53, a tumour suppressor protein. Oncogene, 5, 1683-1690.
27. Milner, J., Cook, A. and Sheldon, M. (1987) A new anti-p53 monoclonal antibody, previously reported to be directed against the large T antigen of simian virus 40. Oncogene, 1, 453-455.
28. Monod, J., Wyman, J. and Changeux, J.P. (1965) On the nature of allosteric transitions: a plausible model. J. Mol. Biol., 12, 88-118.
29. Rolley, N., Butcher, S. and Milner, J. (1995) Specific DNA binding by different classes of human p53 mutants. Oncogene, 11, 763-770.
30. Vojtesek, B. et al. (1995) Conformational changes in p53 analysed using new antibodies to the core DNA binding domain of the protein. Oncogene, 10, 389-393.
31. Waterman, J.L.F., Shenk, J.L. and Halazonetis, T.D. (1995) The dihedral symmetry of the p53 tetramerization domain mandates a conformational switch upon DNA binding. EMBO J., 14, 512-519.
32. Wolkowicz, R., Elkind, N.B., Ronen, D. and Rotter, V. (1995) The DNA binding activity of wild type p53 is modulated by blocking its various antigenic epitopes. Oncogene, 10, 1167-1174.
33. Zhang, W., Funk, W.D., Wright, W.E., Shay, J.W. and Deisseroth, A.B. (1993) Novel DNA binding of p53 mutants and their role in transcriptional activation. Oncogene, 8, 2555-2559.